共 140 条
[21]
Violet J(2018)(68)Ga-PSMA-617 PET/CT: a promising new technique for predicting risk stratification and metastatic risk of prostate cancer patients Eur J Nucl Med Mol Imaging 45 1852-1861
[22]
Shin J(2017)(68)Ga-PSMA PET/CT and volumetric morphology of PET-positive lymph nodes stratified by tumor differentiation of prostate cancer J Nucl Med 58 1949-1955
[23]
Blanksby A(2018)(68)Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer Eur J Nucl Med Mol Imaging 45 1862-1872
[24]
Lee J(2016)Therapeutic response and side effects of repeated radioligand therapy with 177Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer Oncotarget 7 12477-12488
[25]
Haberkorn U(2017)(177)Lu-DKFZ-PSMA-617 therapy in metastatic castration resistant prostate cancer: safety, efficacy, and quality of life assessment Eur J Nucl Med Mol Imaging. 44 81-91
[26]
Eder M(2017)Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [(177)Lu]Lu-PSMA-617 Eur J Nucl Med Mol Imaging. 44 1448-1454
[27]
Kopka K(undefined)undefined undefined undefined undefined-undefined
[28]
Babich JW(undefined)undefined undefined undefined undefined-undefined
[29]
Eisenhut M(undefined)undefined undefined undefined undefined-undefined
[30]
Eisenhauer EA(undefined)undefined undefined undefined undefined-undefined